Baker Bros. Capital (GP), LLC Insider Trading $GHDX GENOMIC HEALTH INC
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Bros. Capital (GP), LLC in GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 194,184 shares
Current Value: $5,338,118
Latest Transaction: Aug 17 2009
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC in GENOMIC HEALTH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.60 | 1 | 20 | 194,184 | 194.2 K to 194.2 K (0.00 %) |
Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.99 | 33 | 660 | 194,183 | 194.2 K to 194.2 K (+0.02 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.70 | 14 | 276 | 194,150 | 194.1 K to 194.2 K (+0.01 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.36 | 5 | 97 | 194,136 | 194.1 K to 194.1 K (0.00 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.37 | 16 | 310 | 194,131 | 194.1 K to 194.1 K (+0.01 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.48 | 4 | 78 | 194,115 | 194.1 K to 194.1 K (0.00 %) |
Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.50 | 6 | 117 | 194,111 | 194.1 K to 194.1 K (0.00 %) |
May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.82 | 3 | 53 | 194,105 | 194.1 K to 194.1 K (0.00 %) |
May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.00 | 12 | 216 | 194,102 | 194.1 K to 194.1 K (+0.01 %) |
May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.88 | 1 | 18 | 194,090 | 194.1 K to 194.1 K (0.00 %) |
May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.98 | 9 | 162 | 194,089 | 194.1 K to 194.1 K (0.00 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.36 | 6 | 116 | 194,080 | 194.1 K to 194.1 K (0.00 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.51 | 27 | 527 | 194,074 | 194 K to 194.1 K (+0.01 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.67 | 19 | 374 | 194,047 | 194 K to 194 K (+0.01 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.54 | 27 | 528 | 194,028 | 194 K to 194 K (+0.01 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 19.53 | 9 | 176 | 194,001 | 194 K to 194 K (0.00 %) |
May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.46 | 6 | 99 | 193,992 | 194 K to 194 K (0.00 %) |
May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.44 | 27 | 444 | 193,986 | 194 K to 194 K (+0.01 %) |
May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.39 | 230 | 3,769 | 193,959 | 193.7 K to 194 K (+0.12 %) |
May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.24 | 282 | 4,581 | 193,729 | 193.4 K to 193.7 K (+0.15 %) |
May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.35 | 136 | 2,224 | 193,447 | 193.3 K to 193.4 K (+0.07 %) |
May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.31 | 30 | 489 | 193,311 | 193.3 K to 193.3 K (+0.02 %) |
May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.40 | 177 | 2,903 | 193,281 | 193.1 K to 193.3 K (+0.09 %) |
May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.67 | 960 | 16,003 | 193,104 | 192.1 K to 193.1 K (+0.50 %) |
May 22 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 15.50 | 1,803 | 27,947 | 192,144 | 190.3 K to 192.1 K (+0.95 %) |
May 21 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 15.50 | 1,803 | 27,947 | 192,144 | 190.3 K to 192.1 K (+0.95 %) |
Mar 13 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.28 | 376 | 6,874 | 190,341 | 190 K to 190.3 K (+0.20 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.02 | 17 | 306 | 189,965 | 189.9 K to 190 K (+0.01 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.77 | 24 | 426 | 189,948 | 189.9 K to 189.9 K (+0.01 %) |
Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.20 | 78 | 1,420 | 189,924 | 189.8 K to 189.9 K (+0.04 %) |
Feb 21 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.54 | 55 | 1,020 | 189,846 | 189.8 K to 189.8 K (+0.03 %) |
Feb 21 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.43 | 1 | 18 | 189,791 | 189.8 K to 189.8 K (0.00 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.36 | 157 | 2,883 | 189,790 | 189.6 K to 189.8 K (+0.08 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.26 | 373 | 6,810 | 189,633 | 189.3 K to 189.6 K (+0.20 %) |
Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.89 | 49 | 877 | 189,260 | 189.2 K to 189.3 K (+0.03 %) |
Page: 1